Patanase Nasal Spray is a prescription antihistamine used to treat symptoms of seasonal allergic rhinitis, commonly known as hay fever.
It works by blocking the effects of histamine, a chemical released by the immune system during allergic reactions. This helps relieve nasal congestion, sneezing, itching, and a runny nose caused by seasonal allergens.
Although Patanase is generally well tolerated, certain precautions are necessary, especially for patients with existing medical conditions, medication allergies, or sensitivity to antihistamines.
Some patients may experience drowsiness, nasal irritation, nosebleeds, or other side effects during treatment.
Use Patanase Nasal Spray exactly as prescribed. Inform your healthcare provider about your medical history, allergies, and other medications before starting treatment.
Use Patanase Only as Prescribed
Patanase is a prescription medication that should only be used according to your healthcare provider’s instructions.
The recommended dosage depends on the patient’s age and individual treatment needs.
For adults and adolescents aged 12 years and older, the usual recommended dosage is two sprays into each nostril twice daily.
For children aged six to 11 years, the recommended dosage is one spray into each nostril twice daily.
Using more medication than prescribed does not necessarily provide faster or better allergy relief.
Excessive use may increase the likelihood of side effects, including nasal irritation, headaches, and drowsiness.
Use Patanase at approximately the same times each day and follow the recommended nasal spraying technique.
If your symptoms remain uncontrolled despite consistent use, contact your healthcare provider rather than increasing the dosage independently.
Do not use Patanase more frequently or in larger amounts than prescribed. Follow your healthcare provider’s dosing instructions carefully.
Medication Interactions With Patanase
Before starting Patanase, tell your healthcare provider about all prescription medications, over-the-counter products, vitamins, and herbal supplements you take.
Although significant drug interactions are not generally expected with olopatadine nasal spray, some medications may increase its sedating effects.
For example, combining Patanase with sleeping pills, certain anxiety medications, sedating antihistamines, or other central nervous system depressants may increase drowsiness and reduce alertness.
Alcohol may also intensify these effects and should be avoided during treatment.
Patanase is not expected to have many interactions involving liver enzymes because olopatadine is eliminated primarily through the kidneys.
However, your healthcare provider should still review your complete medication list to identify potential concerns.
Do not combine Patanase with another antihistamine unless your healthcare provider or pharmacist confirms that the combination is appropriate.
Tell your healthcare provider about all medications and supplements you take. Avoid alcohol and use caution with other medications that cause drowsiness.
Use of Patanase in Children
Patanase may be prescribed to children aged six years and older.
Under U.S. prescribing information, the medication is approved for adults and pediatric patients aged six years and older who experience seasonal allergic rhinitis.
Children aged six to 11 years generally use one spray into each nostril twice daily.
Children aged 12 years and older generally follow the adult dosage of two sprays into each nostril twice daily.
Patanase is not recommended for children younger than six years because its safety and effectiveness have not been established in this age group.
Younger children may require assistance when using the nasal spray to ensure the correct number of sprays is administered.
An adult should supervise treatment and help the child position the applicator correctly.
Parents and caregivers should also monitor for potential side effects, including drowsiness, nosebleeds, and nasal irritation.
Patanase is approved for children aged six years and older under U.S. prescribing information. Children younger than six years should not use the medication, and younger patients should receive adult assistance when needed.
Liver Disease and Kidney Problems
Patients with liver disease or kidney disease should inform their healthcare provider before using Patanase.
The kidneys play an important role in removing olopatadine from the body.
In patients with impaired kidney function, the amount of medication circulating in the bloodstream may increase.
However, the prescribing information does not generally require a dosage adjustment for Patanase solely because of kidney impairment.
Patients with significant kidney disease may still require individual assessment, particularly if they take several medications or have other medical conditions.
Liver impairment is not expected to substantially affect the elimination of olopatadine because the medication undergoes limited metabolism.
Nevertheless, patients with serious liver disease should provide their complete medical history before starting treatment.
Tell your healthcare provider if you have liver or kidney disease. Patanase does not usually require dosage adjustment for these conditions, but individual medical assessment may still be appropriate.
Allergic Reactions to Olopatadine
Do not use Patanase if you have a known allergy to olopatadine hydrochloride or another ingredient in the nasal spray.
An allergic reaction occurs when the immune system responds abnormally to a substance.
Although allergic reactions to olopatadine are uncommon, they may occur in susceptible individuals.
Possible symptoms include itching, skin rash, hives, swelling, or unusual irritation.
Some patients may experience worsening nasal discomfort after administering the medication.
If you develop a new rash, persistent irritation, or other symptoms suggesting an allergic reaction, stop using Patanase and contact your healthcare provider.
In rare cases, a severe allergic reaction may cause swelling of the face, lips, tongue, or throat, along with difficulty breathing.
Do not use Patanase if you have a known allergy to olopatadine or its ingredients. Seek emergency medical attention if you experience difficulty breathing, throat swelling, or other signs of a severe allergic reaction.
Drowsiness and Reduced Alertness
Patanase may cause drowsiness or reduced alertness in some patients.
Although olopatadine is a second-generation antihistamine, some medication can enter the bloodstream after nasal administration.
This may occasionally affect the central nervous system, resulting in sleepiness, fatigue, or reduced concentration.
Patients may be more likely to experience these effects when Patanase is combined with alcohol, sleeping pills, or other sedating medications.
Drowsiness can interfere with driving, operating machinery, or performing activities that require coordination and concentration.
The degree of drowsiness varies between individuals.
Some patients may experience little or no effect, while others may feel noticeably sleepy after treatment.
Until you know how Patanase affects you, avoid activities that could become dangerous if your alertness is reduced.
Avoid driving, operating heavy machinery, or performing hazardous activities if Patanase makes you drowsy. Do not combine it with alcohol or other sedating substances without medical advice.
Eye Irritation and Accidental Eye Exposure
Patanase Nasal Spray is intended for use inside the nose only.
It should not be sprayed directly into the eyes or mouth.
Accidental eye exposure may cause irritation, discomfort, or temporary changes in vision.
When administering Patanase, carefully position the applicator inside the nostril and direct the spray toward the nasal lining.
Avoid pointing the nozzle toward the eyes or face.
If the medication accidentally enters your eyes, rinse them thoroughly with clean water.
If irritation, pain, or blurred vision persists, contact your healthcare provider.
Although olopatadine is also available in specially formulated allergy eye drops, Patanase Nasal Spray is not interchangeable with ophthalmic olopatadine products.
Different formulations are designed for different routes of administration.
Use Patanase only inside the nose. Never apply the nasal spray directly to your eyes, and seek medical advice if accidental exposure causes persistent irritation.
Nosebleeds, Nasal Ulcers, and Nasal Irritation
Patanase may cause local side effects affecting the nasal passages.
These can include nosebleeds, nasal discomfort, irritation, and, less commonly, nasal ulceration.
A nasal ulcer is an open sore that develops in the lining of the nose.
In rare cases, nasal sprays have also been associated with perforation of the nasal septum, the wall separating the two nostrils.
Symptoms may include persistent crusting, recurring nosebleeds, nasal pain, or a whistling sound while breathing.
To reduce irritation, use the correct spraying technique and avoid directing the nozzle toward the nasal septum.
Patients who have recently undergone nasal surgery, experienced nasal injuries, or developed significant nasal sores should inform their healthcare provider before using Patanase.
Your healthcare provider may recommend periodic examination of the nasal lining during prolonged treatment.
Contact your healthcare provider if you develop persistent nosebleeds, nasal sores, worsening irritation, or unusual nasal discomfort. Patanase should be discontinued if nasal ulceration or septal perforation is identified.
Pregnancy and Patanase Nasal Spray
Consult your healthcare provider before using Patanase if you are pregnant, planning to become pregnant, or think you may be pregnant.
There is limited information about the safety of olopatadine nasal spray during human pregnancy.
Animal studies involving high systemic doses of olopatadine have identified certain reproductive effects, although these findings do not necessarily predict the risks associated with recommended nasal doses in humans.
Because Patanase is administered directly into the nasal passages, systemic exposure is generally lower than with some oral medications.
However, some medication may still enter the bloodstream.
Your healthcare provider will consider the severity of your allergy symptoms, your medical history, and available treatment alternatives before recommending Patanase.
If treatment is considered necessary, use the prescribed amount and avoid increasing the dosage.
Patanase should only be used during pregnancy when your healthcare provider determines that the potential benefits outweigh the possible risks.
Breastfeeding and Patanase Nasal Spray
Tell your healthcare provider if you are breastfeeding before starting Patanase.
It is not known whether olopatadine administered through a nasal spray passes into human breast milk in clinically significant amounts.
Animal studies have shown that olopatadine can be present in milk following systemic administration.
However, information about the effects of intranasal olopatadine on breastfed infants is limited.
Because some medication may be absorbed into the bloodstream, your healthcare provider will consider the potential benefits and risks before recommending treatment.
Factors such as the infant’s age, medical condition, and the mother’s need for allergy treatment may influence this decision.
Your healthcare provider may recommend an alternative allergy medication if it has more established breastfeeding safety information.
Consult your healthcare provider before using Patanase while breastfeeding. Do not increase the prescribed dosage or combine it with other antihistamines without medical advice.
Cardiovascular Disease and Patanase
Patients with significant cardiovascular disease should inform their healthcare provider before using Patanase.
Cardiovascular disease includes conditions affecting the heart and blood vessels, such as coronary artery disease, heart failure, and certain heart rhythm disorders.
Patanase is not generally associated with the same cardiovascular risks as stimulant-containing nasal decongestants.
Olopatadine is an antihistamine and does not work by constricting nasal blood vessels in the same way as medications such as pseudoephedrine or oxymetazoline.
Clinical evaluations have not established a major cardiovascular safety concern at recommended nasal doses.
However, patients with serious or unstable cardiovascular conditions should still discuss their medical history and other medications with their healthcare provider.
This is particularly important when multiple medications are being used to manage heart disease.
If you experience chest pain, fainting, or an unexplained rapid or irregular heartbeat, seek medical attention.
Patanase does not carry a specific contraindication for cardiovascular disease, but patients with serious heart conditions should inform their healthcare provider before starting treatment.
Proper Storage of Patanase Nasal Spray
Patanase should be stored according to the manufacturer’s instructions to maintain its quality and effectiveness.
The U.S. prescribing information recommends storing Patanase between 4°C and 25°C (39°F and 77°F).
Keep the bottle away from excessive heat and direct sunlight.
Avoid storing the medication in areas where temperature and humidity change frequently, such as bathrooms.
Always replace the protective cap after use to keep the nasal applicator clean.
Patanase should be kept out of the sight and reach of children and pets to prevent accidental use.
Each bottle is designed to deliver 240 metered sprays.
Discard the bottle after 240 sprays have been used, even if some liquid remains inside, because the manufacturer cannot guarantee accurate dosing beyond this point.
Do not use the medication after its expiration date.
Store Patanase between 4°C and 25°C, keep it away from children and pets, and discard the bottle after 240 metered sprays.
Important Safety Reminders When Using Patanase Nasal Spray
Patanase is a prescription antihistamine used to relieve seasonal allergy symptoms in adults and children aged six years and older.
Although it is generally well tolerated, patients may experience drowsiness, nasal irritation, nosebleeds, headaches, or a bitter taste.
Patients with medication allergies, significant medical conditions, or a history of nasal problems should discuss these concerns with their healthcare provider before starting treatment.
Avoid using Patanase with alcohol or other sedating medications because these combinations may increase drowsiness and reduce alertness.
Do not share your nasal spray with another person because sharing an applicator may spread infections.
Seek emergency medical attention if you develop difficulty breathing, severe facial or throat swelling, or another serious allergic reaction. Contact your healthcare provider if you experience persistent nosebleeds, worsening nasal irritation, or uncontrolled allergy symptoms.
These precautions are not an exhaustive list of all possible warnings associated with Patanase Nasal Spray. Always follow the instructions provided with your prescription.
REVIEWS